表紙
市場調查報告書

全球神經病變性疼痛管理市場:疼痛管理中心數的增加與形成未來的已批准藥物的可得性

Global Market Study of Neuropathic Pain Management: Rise in Number of Pain Management Centers and Availability of Approved Drugs Shaping the Future

出版商 Persistence Market Research 商品編碼 923590
出版日期 內容資訊 英文 182 Pages
商品交期: 2-3個工作天內
價格
全球神經病變性疼痛管理市場:疼痛管理中心數的增加與形成未來的已批准藥物的可得性 Global Market Study of Neuropathic Pain Management: Rise in Number of Pain Management Centers and Availability of Approved Drugs Shaping the Future
出版日期: 2020年01月06日內容資訊: 英文 182 Pages
簡介

本報告提供全球神經病變性疼痛管理市場的相關調查,市場機會和趨勢,成長及阻礙因素,各藥物類別、適應症、流通管道、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 摘要整理

第2章 市場概要

  • 市場調查範圍/分類
  • 市場定義/範圍/限制

第3章 市場動態

  • 宏觀經濟要素
  • 成長要素
    • 供給方面成長要素
    • 需求面成長要素
  • 阻礙因素
  • 市場機會
  • 市場趨勢

第4章 主要總括

  • 臨床試驗

第5章 市場銷售額分析及預測

  • 過去的市場分析
  • 現在、今後的市場預測
    • 與前一年同期比較成長趨勢分析

第6章 市場分析:各類藥物

  • 簡介/主要調查結果
  • 過去的市場分析
  • 現在、今後的市場分析及預測
    • 三環抗憂鬱藥物
    • 抗痙攣藥
    • SNRI
    • 辣椒素霜
    • 局部麻醉
    • 類鴉片物質
    • 類固醇
    • 其他
  • 市場魅力分析

第7章 市場分析:各適應症

  • 簡介/主要調查結果
  • 過去的市場分析
  • 現在、今後的市場分析及預測
    • 糖尿病神經病變
    • 三叉神經痛
    • 皰疹後神經痛
    • 化療誘發性末梢神經病變
    • 其他
  • 市場魅力分析

第8章 市場分析:各流通管道

  • 簡介/主要調查結果
  • 過去的市場分析
  • 現在、今後的市場分析及預測
    • 零售藥局
    • 醫院藥局
    • 線上藥局
  • 市場魅力分析

第9章 市場分析:各地區

  • 簡介
  • 過去的市場分析
  • 目前市場分析及預測
    • 北美
    • 南美
    • 歐洲
    • 亞太地區
    • 中東、非洲
  • 市場魅力分析

第10章 北美

第11章 南美

第12章 歐洲

第13章 亞太地區

第14章 中東及非洲

第15章 競爭情形

  • 競爭儀表板
  • 競爭詳細內容
    • Pfizer Inc.
    • Johnson & Johnson Services, Inc.
    • Bristol-Myers Squibb Company
    • Sanofi S.A
    • GlaxoSmithKline plc
    • Eli Lilly and Company
    • Teva Pharmaceutical Industries Ltd
    • Baxter International Inc

第16章 前提條件與簡稱的使用

第17章 調查方法

目錄

Scope of the Report

Persistence Market Research (PMR) recently published a market study on the global market for neuropathic pain management. The study provides detailed assessment on the key market dynamics, including drivers, trends, opportunities restraints, and detailed information about the neuropathic pain management market structure. The market study presents exclusive information about how the neuropathic pain management market will grow during the forecast period of 2019-2029.

Key indicators of market growth, which include Year-on-Year (Y-o-Y) growth of the market, and compounded annual growth rate (CAGR) are explained in PMR's study in a comprehensive manner. This information can help readers understand the quantitative growth prospects of the neuropathic pain management market during the forecast period.

The study is relevant for stakeholders in the neuropathic pain management market, including neuropathic pain management therapy manufacturers, suppliers, distributors, and investors, and can help them in developing appropriate strategies to grow in the market. Stakeholders in the neuropathic pain management market, investors, industry experts, researchers, and journalists, as well as business researchers can leverage the information and data presented in PMR's study.

The study also includes statistics as well as facts related to macro as well as microeconomic factors that are impacting developments in the market. It also offers actionable insights based on the future trends in the neuropathic pain management market. Furthermore, small businesses and new entrants in the neuropathic pain management market too can make use of the information presented in this study, based on which, they can make appropriate business decisions to gain momentum in the market.

Key Questions Answered:

  • Which regions will continue to remain the most profitable regional markets for neuropathic pain management market players?
  • Which factors will induce a change in the demand for neuropathic pain management therapy during the assessment period?
  • How will changing trends impact the neuropathic pain management market?
  • How can market players capture the low-hanging opportunities in the neuropathic pain management market in developed regions?
  • Which companies are leading the neuropathic pain management market?
  • What are the winning strategies of stakeholders in the neuropathic pain management market to upscale their position in this landscape?

Research Methodology

In PMR's study, a unique research methodology is utilized to conduct extensive research on the growth of the neuropathic pain management market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure accuracy and reliability of the conclusions.

Secondary resources referred to analysts during the production of the neuropathic pain management market study include statistics from government organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary resources and secondary resources acts as a validation from companies in the neuropathic pain management market, and makes PMR's projection on the growth prospects of the neuropathic pain management market more accurate and reliable.

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Market Dynamics

  • 3.1. Macro-Economic Factors
  • 3.2. Drivers
    • 3.2.1. Supply Side Drivers
    • 3.2.2. Demand Side Drivers
  • 3.3. Restraints
  • 3.4. Opportunities
  • 3.5. Trends

4. Key Inclusions

  • 4.1. Clinical Trials

5. Global Neuropathic Pain Management Market Value Analysis 2014-2018 and Forecast, 2019-2029

  • 5.1. Historical Market Value (US$ Mn) Analysis, 2014-2018
  • 5.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029
    • 5.2.1. Y-o-Y Growth Trend Analysis
    • 5.2.2. Absolute $ Opportunity Analysis

6. Global Neuropathic Pain Management Market Analysis 2014-2018 and Forecast 2019-2029, by Drug Class

  • 6.1. Introduction / Key Findings
  • 6.2. Historical Market Size (US$ Mn) Analysis By Drug Class, 2014-2018
  • 6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug Class, 2019 - 2029
    • 6.3.1. Tricyclic Anti-Depressants
    • 6.3.2. Anticonvulsants
    • 6.3.3. SNRI's
    • 6.3.4. Capsaicin Cream
    • 6.3.5. Local Anaesthesia
    • 6.3.6. Opioids
    • 6.3.7. Steroids
    • 6.3.8. Others
  • 6.4. Market Attractiveness Analysis By Drug Class

7. Global Neuropathic Pain Management Market Analysis 2014-2018 and Forecast 2019-2029, by Indication

  • 7.1. Introduction / Key Findings
  • 7.2. Historical Market Size (US$ Mn) Analysis By Indication, 2014-2018
  • 7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2019 - 2029
    • 7.3.1. Diabetic Neuropathy
    • 7.3.2. Trigeminal Neuralgia
    • 7.3.3. Post-Herpetic Neuralgia
    • 7.3.4. Chemotherapy-Induced Peripheral Neuropathy
    • 7.3.5. Others
  • 7.4. Market Attractiveness Analysis By Indication

8. Global Neuropathic Pain Management Market Analysis 2014-2018 and Forecast 2019-2029, by Distribution Channel

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2014-2018
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2019 - 2029
    • 8.3.1. Retail Pharmacies
    • 8.3.2. Hospital Pharmacies
    • 8.3.3. Online Pharmacies
  • 8.4. Market Attractiveness Analysis By Distribution Channel

9. Global Neuropathic Pain Management Market Analysis 2014-2018 and Forecast 2019-2029, by Region

  • 9.1. Introduction
  • 9.2. Historical Market Size (US$ Mn) Analysis By Region, 2014-2018
  • 9.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019 - 2029
    • 9.3.1. North America
    • 9.3.2. Latin America
    • 9.3.3. Europe
    • 9.3.4. Asia Pacific
    • 9.3.5. Middle East and Africa
  • 9.4. Market Attractiveness Analysis By Region

10. North America Neuropathic Pain Management Market Analysis 2014-2018 and Forecast 2019-2029

  • 10.1. Introduction
  • 10.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
  • 10.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029
    • 10.3.1. By Country
      • 10.3.1.1. U.S.
      • 10.3.1.2. Canada
    • 10.3.2. By Drug Class
    • 10.3.3. By Indication
    • 10.3.4. By Distribution Channel
  • 10.4. Market Attractiveness Analysis
  • 10.5. Key Impact Analysis

11. Latin America Neuropathic Pain Management Market Analysis 2014-2018 and Forecast 2019-2029

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
  • 11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029
    • 11.3.1. By Country
      • 11.3.1.1. Brazil
      • 11.3.1.2. Mexico
      • 11.3.1.3. Argentina
      • 11.3.1.4. Rest of Latin America
    • 11.3.2. By Drug Class
    • 11.3.3. By Indication
    • 11.3.4. By Distribution Channel
  • 11.4. Market Attractiveness Analysis
  • 11.5. Key Impact Analysis

12. Europe Neuropathic Pain Management Market Analysis 2014-2018 and Forecast 2019-2029

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
  • 12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029
    • 12.3.1. By Country
      • 12.3.1.1. U.K.
      • 12.3.1.2. Germany
      • 12.3.1.3. France
      • 12.3.1.4. Italy
      • 12.3.1.5. Spain
      • 12.3.1.6. Russia
      • 12.3.1.7. Rest of Europe
    • 12.3.2. By Drug Class
    • 12.3.3. By Indication
    • 12.3.4. By Distribution Channel
  • 12.4. Market Attractiveness Analysis
  • 12.5. Key Impact Analysis

13. Asia Pacific Neuropathic Pain Management Market Analysis 2014-2018 and Forecast 2019-2029

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
  • 13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029
    • 13.3.1. By Country
      • 13.3.1.1. China
      • 13.3.1.2. India
      • 13.3.1.3. Australia and NZ
      • 13.3.1.4. ASEAN
      • 13.3.1.5. Rest of Asia Pacific
    • 13.3.2. By Drug Class
    • 13.3.3. By Indication
    • 13.3.4. By Distribution Channel
  • 13.4. Market Attractiveness Analysis
  • 13.5. Key Impact Analysis

14. Middle East and Africa Neuropathic Pain Management Market Analysis 2014-2018 and Forecast 2019-2029

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
  • 14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029
    • 14.3.1. By Country
      • 14.3.1.1. GCC Countries
      • 14.3.1.2. South Africa
      • 14.3.1.3. Rest of MEA
    • 14.3.2. By Drug Class
    • 14.3.3. By Indication
    • 14.3.4. By Distribution Channel
  • 14.4. Market Attractiveness Analysis
  • 14.5. Key Impact Analysis

15. Competition Analysis

  • 15.1. Competition Dashboard
  • 15.2. Competition Deep Dive
    • 15.2.1. Pfizer Inc.
      • 15.2.1.1. Company Overview
      • 15.2.1.2. Segment Overview
      • 15.2.1.3. ProductOfferings
      • 15.2.1.4. Financial Analysis
      • 15.2.1.5. Key Developments
      • 15.2.1.6. Strategy Overview
    • 15.2.2. Johnson & Johnson Services, Inc.
      • 15.2.2.1. Company Overview
      • 15.2.2.2. Segment Overview
      • 15.2.2.3. ProductOfferings
      • 15.2.2.4. Financial Analysis
      • 15.2.2.5. Key Developments
      • 15.2.2.6. Strategy Overview
    • 15.2.3. Bristol-Myers Squibb Company
      • 15.2.3.1. Company Overview
      • 15.2.3.2. Segment Overview
      • 15.2.3.3. ProductOfferings
      • 15.2.3.4. Financial Analysis
      • 15.2.3.5. Key Developments
      • 15.2.3.6. Strategy Overview
    • 15.2.4. Sanofi S.A
      • 15.2.4.1. Company Overview
      • 15.2.4.2. Segment Overview
      • 15.2.4.3. ProductOfferings
      • 15.2.4.4. Financial Analysis
      • 15.2.4.5. Key Developments
      • 15.2.4.6. Strategy Overview
    • 15.2.5. GlaxoSmithKline plc
      • 15.2.5.1. Company Overview
      • 15.2.5.2. Segment Overview
      • 15.2.5.3. ProductOfferings
      • 15.2.5.4. Financial Analysis
      • 15.2.5.5. Key Developments
      • 15.2.5.6. Strategy Overview
    • 15.2.6. Eli Lilly and Company
      • 15.2.6.1. Company Overview
      • 15.2.6.2. Segment Overview
      • 15.2.6.3. ProductOfferings
      • 15.2.6.4. Financial Analysis
      • 15.2.6.5. Key Developments
      • 15.2.6.6. Strategy Overview
    • 15.2.7. Teva Pharmaceutical Industries Ltd
      • 15.2.7.1. Company Overview
      • 15.2.7.2. Segment Overview
      • 15.2.7.3. ProductOfferings
      • 15.2.7.4. Financial Analysis
      • 15.2.7.5. Key Developments
      • 15.2.7.6. Strategy Overview
    • 15.2.8. Baxter International Inc
      • 15.2.8.1. Company Overview
      • 15.2.8.2. Segment Overview
      • 15.2.8.3. ProductOfferings
      • 15.2.8.4. Financial Analysis
      • 15.2.8.5. Key Developments
      • 15.2.8.6. Strategy Overview

16. Assumptions and Acronyms Used

17. Research Methodology

List of Tables

  • Table 01: Global Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class
  • Table 02: Global Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication
  • Table 03: Global Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel
  • Table 04: Global Neuropathic Pain Management Size (US$ Mn) 2014-2018 and Forecast 2019-2029 By Region,
  • Table 05: North America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
  • Table 06: North America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class
  • Table 07: North America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication
  • Table 08: North America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel
  • Table 09: Latin America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
  • Table 10: Latin America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class
  • Table 11: Latin America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication
  • Table 12: Latin America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel
  • Table 13: Europe Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
  • Table 14: Europe Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class
  • Table 15: Europe Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication
  • Table 16: Europe Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel
  • Table 17: Asia-Pacific Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
  • Table 18: Asia-Pacific Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class
  • Table 19: Asia-Pacific Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication
  • Table 20: Asia-Pacific Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel
  • Table 21: MEA Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
  • Table 22: MEA Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class
  • Table 23: MEA Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication
  • Table 24: MEA Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel

List of Figures

  • Figure 01: Global Neuropathic Pain Management Market Value Share By Drug Class (2019 E)
  • Figure 02: Global Neuropathic Pain Management Market Value Share By Indication (2019 E)
  • Figure 03: Global Neuropathic Pain Management Market Value Share By Distribution Channel (2019 E)
  • Figure 04: Global Neuropathic Pain Management Market Value Share By Region (2019 E)
  • Figure 05: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
  • Figure 06: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
  • Figure 07: Global Neuropathic Pain Management Market Absolute $ Opportunity, 2018 - 2026
  • Figure 08: Global Neuropathic Pain Management Market Share Analysis (%), By Drug Class, 2018 & 2026
  • Figure 09: Global Neuropathic Pain Management Market Y-o-Y Analysis (%), By Drug Class, 2019-2029
  • Figure 10: Global Neuropathic Pain Management Market Attractiveness Analysis By Drug Class, 2019-2029
  • Figure 11: Global Neuropathic Pain Management Market Share Analysis (%), By Indication , 2018 & 2026
  • Figure 12: Global Neuropathic Pain Management Market Y-o-Y Analysis (%), By Indication , 2019-2029
  • Figure 13: Global Neuropathic Pain Management Market Attractiveness Analysis By Indication, 2019-2029
  • Figure 14: Global Neuropathic Pain Management Market Share Analysis (%), By Distribution Channel, 2018 & 2026
  • Figure 15: Global Neuropathic Pain Management Market Y-o-Y Analysis (%), By Distribution Channel, 2019-2029
  • Figure 16: Global Neuropathic Pain Management Market Attractiveness Analysis By Distribution Channel, 2019-2029
  • Figure 17: Global Neuropathic Pain Management Market Share Analysis (%), By Region, 2018 & 2026
  • Figure 18: Global Neuropathic Pain Management Market Y-o-Y Analysis (%), By Region, 2019-2029
  • Figure 19: Global Neuropathic Pain Management Market Attractiveness Analysis By Region, 2019-2029
  • Figure 20: North America Neuropathic Pain Management Market Value Share By Drug Class (2019 E)
  • Figure 21: North America Neuropathic Pain Management Market Value Share By Indication (2019 E)
  • Figure 22: North America Neuropathic Pain Management Market Value Share By Distribution Channel (2019 E)
  • Figure 23: North America Neuropathic Pain Management Market Value Share By Country (2019 E)
  • Figure 24: North America Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
  • Figure 25: North America Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
  • Figure 26: U.S. Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
  • Figure 27: U.S. Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
  • Figure 28: Canada Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
  • Figure 29: Canada Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
  • Figure 30: North America Neuropathic Pain Management Market Attractiveness Analysis By Drug Class, 2019-2029
  • Figure 31: North America Neuropathic Pain Management Market Attractiveness Analysis By Indication, 2019-2029
  • Figure 32: North America Neuropathic Pain Management Market Attractiveness Analysis By Distribution Channel, 2019-2029
  • Figure 33: North America Neuropathic Pain Management Market Attractiveness Analysis By Country, 2019-2029
  • Figure 34: Latin America Neuropathic Pain Management Market Value Share By Drug Class (2019 E)
  • Figure 35: Latin America Neuropathic Pain Management Market Value Share By Indication (2019 E)
  • Figure 36: Latin America Neuropathic Pain Management Market Value Share By Distribution Channel (2019 E)
  • Figure 37: Latin America Neuropathic Pain Management Market Value Share By Country (2019 E)
  • Figure 38: Latin America Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
  • Figure 39: Latin America Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
  • Figure 40: Brazil Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
  • Figure 41: Brazil Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
  • Figure 42: Mexico Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
  • Figure 43: Mexico Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
  • Figure 44: Argentina Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
  • Figure 45: Argentina Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
  • Figure 46: Rest of Latin America Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
  • Figure 47: Rest of Latin America Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
  • Figure 48: Latin America Neuropathic Pain Management Market Attractiveness Analysis By Drug Class, 2019-2029
  • Figure 49: Latin America Neuropathic Pain Management Market Attractiveness Analysis By Indication, 2019-2029
  • Figure 50: Latin America Neuropathic Pain Management Market Attractiveness Analysis By Distribution Channel, 2019-2029
  • Figure 51: Latin America Neuropathic Pain Management Market Attractiveness Analysis By Country, 2019-2029
  • Figure 52: Europe Neuropathic Pain Management Market Value Share By Drug Class (2019 E)
  • Figure 53: Europe Neuropathic Pain Management Market Value Share By Indication (2019 E)
  • Figure 54: Europe Neuropathic Pain Management Market Value Share By Distribution Channel (2019 E)
  • Figure 55: Europe Neuropathic Pain Management Market Value Share By Country (2019 E)
  • Figure 56: Europe Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
  • Figure 57: Europe Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
  • Figure 58: U.K. Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
  • Figure 59: U.K. Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
  • Figure 60: Germany Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
  • Figure 61: Germany Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
  • Figure 62: France Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
  • Figure 63: France Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
  • Figure 64: Italy Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
  • Figure 65: Italy Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
  • Figure 66: Spain Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
  • Figure 67: Spain Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
  • Figure 68: Russia Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
  • Figure 69: Russia Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
  • Figure 70: Rest of Europe Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
  • Figure 71: Rest of Europe Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
  • Figure 72: Europe Neuropathic Pain Management Market Attractiveness Analysis By Drug Class, 2019-2029
  • Figure 73: Europe Neuropathic Pain Management Market Attractiveness Analysis By Indication, 2019-2029
  • Figure 74: Europe Neuropathic Pain Management Market Attractiveness Analysis By Distribution Channel, 2019-2029
  • Figure 75: Europe Neuropathic Pain Management Market Attractiveness Analysis By Country, 2019-2029
  • Figure 76: Asia-Pacific Neuropathic Pain Management Market Value Share By Drug Class (2019 E)
  • Figure 77: Asia-Pacific Neuropathic Pain Management Market Value Share By Indication (2019 E)
  • Figure 78: Asia-Pacific Neuropathic Pain Management Market Value Share By Distribution Channel (2019 E)
  • Figure 79: Asia-Pacific Neuropathic Pain Management Market Value Share By Country (2019 E)
  • Figure 80: Asia-Pacific Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
  • Figure 81: Asia-Pacific Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
  • Figure 82: Japan Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
  • Figure 83: Japan Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
  • Figure 84: China Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
  • Figure 85: China Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
  • Figure 86: India Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
  • Figure 87: India Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
  • Figure 88: Australia & New Zealand Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
  • Figure 89: Australia & New Zealand Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
  • Figure 90: ASEAN Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
  • Figure 91: ASEAN Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
  • Figure 92: Rest of APAC Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
  • Figure 93: Rest of APAC Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
  • Figure 94: Asia-Pacific Neuropathic Pain Management Market Attractiveness Analysis By Drug Class, 2019-2029
  • Figure 95: Asia-Pacific Neuropathic Pain Management Market Attractiveness Analysis By Indication, 2019-2029
  • Figure 96: Asia-Pacific Neuropathic Pain Management Market Attractiveness Analysis By Distribution Channel, 2019-2029
  • Figure 97: Asia-Pacific Neuropathic Pain Management Market Attractiveness Analysis By Country, 2019-2029
  • Figure 98: MEA Neuropathic Pain Management Market Value Share By Drug Class (2019 E)
  • Figure 99: MEA Neuropathic Pain Management Market Value Share By Indication (2019 E)
  • Figure 100: MEA Neuropathic Pain Management Market Value Share By Distribution Channel (2019 E)
  • Figure 101: MEA Neuropathic Pain Management Market Value Share By Country (2019 E)
  • Figure 102: MEA Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
  • Figure 103: MEA Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
  • Figure 104: South Africa Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
  • Figure 105: South Africa Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
  • Figure 106: GCC Countries Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
  • Figure 107: GCC Countries Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
  • Figure 108: Rest of MEA Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
  • Figure 109: Rest of MEA Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
  • Figure 110: MEA Neuropathic Pain Management Market Attractiveness Analysis By Drug Class, 2019-2029
  • Figure 111: MEA Neuropathic Pain Management Market Attractiveness Analysis By Indication, 2019-2029
  • Figure 112: MEA Neuropathic Pain Management Market Attractiveness Analysis By Distribution Channel, 2019-2029
  • Figure 113: MEA Neuropathic Pain Management Market Attractiveness Analysis By Country, 2019-2029